Constantly changing regulations and a multitude of new endpoints continue to keep clinical researchers on their toes. While these regulations and endpoints are designed to keep patients safe, they often create unintended barriers that keep patients out of clinical trials. In this episode, we discuss with Kafayat Babajide, Director of Patient Insights & Experience with Johnson and Johnson, the ways in which a patient-centric approach can remove controllable barriers from the clinical trial process and strengthen your patient engagement.
Australia and New Zealand have not been impacted as much as North America and the EU with regards to COVID-19. For this reason, and...
Patients are no longer passive research subjects, but rather being integrated into the research process from the start. Patient advocates help with such integrations,...
Phastar and Medrio have been partnering together on trials for the past 3 years, culminating in a unique way to visualize clinical trial data....